Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C S Liu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigensJoshua R Ehrlich, Liangdan Tang, Robert J Caiazzo, et al.
Journal of Cellular and Molecular Medicine|October 6, 2005
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblastN K Mukhopadhyay, G J Gordon, G Maulik, et al.
Proteomics. Clinical Applications|August 5, 2015
Protein microarrays as an application for disease biomarkersRobert J Caiazzo, Andrew J Maher, Michael P Drummond, et al.
Experimental Cell Research|October 3, 2006
Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptorNishit K Mukhopadhyay, Angeline S Ferdinand, Lipi Mukhopadhyay, et al.
Expert Review of Molecular Diagnostics|October 13, 2009
Microelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnosticsDavid L Arruda, William C Wilson, Crystal Nguyen, et al.
Proteomics|April 6, 2006
Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profilingShuzhen Qin, Weiliang Qiu, Joshua R Ehrlich, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 8, 2011
Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigenDennis J O'Rourke, Daniel A DiJohnson, Robert J Caiazzo, et al.
Cancer|December 12, 2003
Prostate carcinoma tissue proteomics for biomarker discoveryYaxin Zheng, Ye Xu, Bin Ye, et al.
The Journal of Urology|January 16, 2007
A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasiaGrant W Cannon, Chris Mullins, M Scott Lucia, et al.
Clinical Chemistry|October 15, 2010
CA125 immune complexes in ovarian cancer patients with low CA125 concentrationsDaniel W Cramer, Dennis J O'Rourke, Allison F Vitonis, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigensJoshua R Ehrlich, Liangdan Tang, Robert J Caiazzo, et al.
Journal of Cellular and Molecular Medicine|October 6, 2005
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblastN K Mukhopadhyay, G J Gordon, G Maulik, et al.
Proteomics. Clinical Applications|August 5, 2015
Protein microarrays as an application for disease biomarkersRobert J Caiazzo, Andrew J Maher, Michael P Drummond, et al.
Experimental Cell Research|October 3, 2006
Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptorNishit K Mukhopadhyay, Angeline S Ferdinand, Lipi Mukhopadhyay, et al.
Expert Review of Molecular Diagnostics|October 13, 2009
Microelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnosticsDavid L Arruda, William C Wilson, Crystal Nguyen, et al.
Proteomics|April 6, 2006
Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profilingShuzhen Qin, Weiliang Qiu, Joshua R Ehrlich, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 8, 2011
Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigenDennis J O'Rourke, Daniel A DiJohnson, Robert J Caiazzo, et al.
Cancer|December 12, 2003
Prostate carcinoma tissue proteomics for biomarker discoveryYaxin Zheng, Ye Xu, Bin Ye, et al.
The Journal of Urology|January 16, 2007
A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasiaGrant W Cannon, Chris Mullins, M Scott Lucia, et al.
Clinical Chemistry|October 15, 2010
CA125 immune complexes in ovarian cancer patients with low CA125 concentrationsDaniel W Cramer, Dennis J O'Rourke, Allison F Vitonis, et al.
Pageof 3